The present invention relates to an oral extract composition comprising Shatavari (
Asparagus racemosus Willd.) and Fenugreek (
Trigonella foenum-graecum L.) extract composition, and its process of preparation. Also relates to the oral extract composition formulation comprising with synergistic combinations of the Shatavari (
Asparagus racemosus Willd.) and Fenugreek (
Trigonella foenum-graecum L.) in suitable doses and at least one nutraceutically and / or pharmaceutically accepted
excipient for, improvement, and maintenance of women health more preferably in improving of hot flashes, night sweats,
poor sleep,
anxiety,
sexual dysfunction,
mood changes, Genitourinary symptoms in overall improving the
quality of life, serum estradiol, progesterone,
follicle stimulating
hormone (FSH), and cortisol during the period of
menopause (perimenopause and
menopause). The oral extract composition formulation comprising with synergistic combinations of the Shatavari (
Asparagus racemosus Willd.) and Fenugreek (
Trigonella foenum-graecum L.) in suitable doses and at least one nutraceutically and / or pharmaceutically accepted
excipient is used for improving Brain-derived neurotrophic factor (BDNF) levels in women during the period of
menopause. The present invention, further related to the extraction process of Shatavari (
Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.), also provides the process for the preparation of formulation composition. This invention further relates to the extraction process from Shatavari (
Asparagus racemosus Willd.) and Fenugreek (Trigonella foenum-graecum L.) either as individual herbs or co-extraction of the two herbs or mixing the extracts at various stages of the individual extracts.